{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Andrew", "organization": "", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "news_desk": "Business", "slideshow_credits": null, "abstract": "Researchers report Mapp Biopharmaceutical drug ZMapp apparently prevents death from Ebola in its first rigorous clinical trial; say results, however, are inconclusive.", "multimedia": [], "headline": {"print_headline": "Ebola Drug Shows Signs of Efficacy in Small Trial", "main": "Ebola Drug Shows Signs of Efficacy in Small Clinical Trial"}, "print_page": "3", "keywords": [{"value": "Ebola Virus", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "ZMapp (Drug)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Mapp Biopharmaceutical Inc", "is_major": "Y", "rank": "3", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Africa", "is_major": "N", "rank": "5", "name": "glocations"}], "snippet": "ZMapp, a potential treatment for Ebola, seemed to prevent death in its first rigorous trial, but researchers said the results were not conclusive.", "source": "The New York Times", "lead_paragraph": "ZMapp, a potential treatment for Ebola, seemed to prevent death in its first rigorous trial, but researchers said the results were not conclusive.", "word_count": "519", "pub_date": "2016-02-24T00:00:00Z", "subsection_name": null, "blog": [], "type_of_material": "News", "section_name": "Health", "web_url": "http://www.nytimes.com/2016/02/24/science/ebola-drug-shows-signs-of-efficacy-in-small-clinical-trial.html", "_id": "56cd33aa38f0d838c6ea4c14"}